跳至主要内容
临床试验/NL-OMON47931
NL-OMON47931招募中不适用

Platelet RNA profiling to screen for cancer in patients with unprovoked venous thromboembolism - Tumour-educated platelets in venous thromboembolism

Academisch Medisch Centrum0 个研究点目标入组 270 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - First, objectively confirmed, symptomatic, unprovoked symptomatic pulmonary
  • embolism and/or distal or proximal deep vein thrombosis of the leg
  • - Age 40 years or older
  • - Written informed consent

排除标准

  • - One or more of the following risk factors for veneuze trombo-embolie (VTE):
  • - known malignant disease prior to VTE defined as a cancer diagnosis or
  • cancer treatment within the past 5 years;
  • - trauma or fracture of the leg, surgical procedures, general anesthesia, or
  • immobilization greater than 3 days within previous 3 months;
  • - previous unprovoked venous thromboembolism;
  • - known hereditary or acquired thrombophilia;
  • - current pregnancy or puerperium (up to 3 months postpartum);
  • - current estrogen therapy.
  • - Greater than 10 days after VTE diagnosis;
  • - Inability for blood withdrawal at baseline;
  • - Inability or refusal to provide written informed consent

研究者

相似试验